View Cart (0 items)

Pharmaceutical

Jury Orders J&J to Pay $482 Million in Patent Lawsuit

January 31, 2011
The Associated Press reports, a federal jury in Texas has ordered Johnson & Johnson and a subsidiary to pay $482 million in damages to an inventor who claimed the health
Read More

Genzyme to Build New Belgium Plant

January 24, 2011
Genzyme Corp has announced it will build a new plant in Belgium to produce Lumizyme, its treatment for Pompe disease, a rare genetic disease. Lumizyne is known as Myozyme outside
Read More

Merck Opens New Application and Technology Centre in India

January 6, 2011
India PRwire reports, Global Pharmaceutical and Chemical Company, Merck Limited, opened its new Application and Technology Centre at Nerul, Navi Mumbai. Spread over 1700 sq. ft., the state-of-the-art Centre will
Read More

Novartis to Invest $500 Million in Russia

December 20, 2010
The Associated Press reports, Swiss pharmaceutical company Novartis AG says it plans to invest $500 million in Russia over a five-year period. Novartis says the investment will include the construction
Read More

Sanofi-Aventis Extends Genzyme Offer

December 13, 2010
The Associated Press reports, French pharmaceutical group Sanofi-Aventis is extending its unsolicited $18.5 billion takeover offer for U.S.-based biotech company Genzyme until Jan. 21. The previous $69-per-share offer expired
Read More

Pfizer CEO Kindler Resigns

December 6, 2010
After more than four years at the helm, Pfizer Inc.’s President and CEO Jeffrey Kindler has resigned from the company, reports the Associated Press. The New York-based pharmaceutical company''s
Read More

GlaxoSmithKline Poised to Create 1,000 Jobs in UK

November 29, 2010
The Press Association reports, GlaxoSmithKline will create around 1,000 jobs and invest £500 million in manufacturing following tax reforms announced by the Government. GlaxoSmithKline said a ten percent reduction
Read More

Arthritis Study Propels Pfizer Into $12 Billion Market

November 8, 2010
Pfizer Inc.’s experimental pill for rheumatoid arthritis reduced pain and inflammation for 71 percent of patients in a study that may help the company with $12 billion in yearly
Read More

Novartis Expands Global Research Center, Adding Jobs

November 1, 2010
In a press release, Novartis announced that it will add 300 new jobs and invest $600 million over the next five years to expand its global research headquarters campus in
Read More

Biocon and Pfizer Enter Into Global Commercialization Agreement

October 18, 2010
PRNewswire reports, Asia''s premier biotechnology company, Biocon, and Pfizer Inc. announced they have entered into a strategic global agreement for the worldwide commercialization of Biocon''s biosimilar versions of Insulin and
Read More